Literature DB >> 36001229

A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy.

Kang Wang1, Yanjun Xiang1, Jiangpeng Yan2,3, Yuyao Zhu4, Hanbo Chen2, Jianhua Yao5, Shuqun Cheng6,7,8, Hongming Yu1, Yuqiang Cheng1, Xiu Li3, Wei Dong4, Yan Ji2, Jingjing Li9, Dong Xie9, Wan Yee Lau1,10.   

Abstract

INTRODUCTION: Microvascular invasion (MVI) is a known risk factor for prognosis after R0 liver resection for hepatocellular carcinoma (HCC). The aim of this study was to develop a deep learning prognostic prediction model by incorporating a new factor of MVI area to the other independent risk factors.
METHODS: Consecutive patients with HCC who underwent R0 liver resection from January to December 2016 at the Eastern Hepatobiliary Surgery Hospital were included in this retrospective study. For patients with MVI detected on resected specimens, they were divided into two groups according to the size of the maximal MVI area: the small-MVI group and the large-MVI group.
RESULTS: Of 193 patients who had MVI in the 337 HCC patients, 130 patients formed the training cohort and 63 patients formed the validation cohort. The large-MVI group of patients had worse overall survival (OS) when compared with the small-MVI group (p = 0.009). A deep learning model was developed based on the following independent risk factors found in this study: MVI stage, maximal MVI area, presence/absence of cirrhosis, and maximal tumor diameter. The areas under the receiver operating characteristic of the deep learning model for the 1-, 3-, and 5-year predictions of OS were 80.65, 74.04, and 79.44, respectively, which outperformed the traditional COX proportional hazards model.
CONCLUSION: The deep learning model, by incorporating the maximal MVI area as an additional prognostic factor to the other previously known independent risk factors, predicted more accurately postoperative long-term OS for HCC patients with MVI after R0 liver resection.
© 2022. Asian Pacific Association for the Study of the Liver.

Entities:  

Keywords:  Computer-aided diagnosis; Deep learning; Hepatocellular carcinoma; Microvascular invasion; Nomogram; Novel model; Overall survival; Pathology; R0 liver resection; Whole section images

Mesh:

Year:  2022        PMID: 36001229     DOI: 10.1007/s12072-022-10393-w

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   9.029


  43 in total

1.  Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China.

Authors:  Zhen-Hua Chen; Xiu-Ping Zhang; Jin-Kai Feng; Le-Qun Li; Fan Zhang; Yi-Ren Hu; Cheng-Qian Zhong; Jie Shi; Wei-Xing Guo; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal:  Hepatol Int       Date:  2021-04-05       Impact factor: 6.047

Review 2.  Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.

Authors:  Xiaofeng Zhang; Jun Li; Feng Shen; Wan Yee Lau
Journal:  J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 4.029

Review 3.  Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria.

Authors:  K-C Lim; P K-H Chow; J C Allen; F J Siddiqui; E S-Y Chan; S-B Tan
Journal:  Br J Surg       Date:  2012-09-28       Impact factor: 6.939

4.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

5.  The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.

Authors:  Shuji Sumie; Osamu Nakashima; Koji Okuda; Ryoko Kuromatsu; Atsushi Kawaguchi; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Maisa Hori; Tatsuyuki Kakuma; Takuji Torimura; Michio Sata
Journal:  Ann Surg Oncol       Date:  2013-11-20       Impact factor: 5.344

6.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

7.  Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria.

Authors:  Kheng-Choon Lim; Pierce Kah-Hoe Chow; John C Allen; Ghim-Song Chia; Miaoshan Lim; Peng-Chung Cheow; Alexander Y F Chung; London L P Ooi; Say-Beng Tan
Journal:  Ann Surg       Date:  2011-07       Impact factor: 12.969

8.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.

Authors:  Sasan Roayaie; Iris N Blume; Swan N Thung; Maria Guido; Maria-Isabel Fiel; Spiros Hiotis; Daniel M Labow; Josep M Llovet; Myron E Schwartz
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

Review 9.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.

Authors:  Wen-Ming Cong; Hong Bu; Jie Chen; Hui Dong; Yu-Yao Zhu; Long-Hai Feng; Jun Chen
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

10.  Prognostic Value of Microvascular Invasion in Eight Existing Staging Systems for Hepatocellular Carcinoma: A Bi-Centeric Retrospective Cohort Study.

Authors:  Yan-Jun Xiang; Kang Wang; Yi-Tao Zheng; Hong-Ming Yu; Yu-Qiang Cheng; Wei-Jun Wang; Yun-Feng Shan; Shu-Qun Cheng
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.